For example, miR-3188 significantly inhibits the development of nasopharyngeal carcinoma by targeting mTOR to inactive the p-PI3K/p-AKT/p-mTOR pathway 17; and the deficiency of miRNA-150 leads to inhibition of differentiation of intraepithelial lymphocytes 14. Here, MTOR is linked to nasopharyngeal carcinoma.